S31 

Case Report: Eclampsia in a Post COVID-19 Patient 

Ehsan Rosdi1 

 
COVID-19 infection has attracted many clinicians and researchers to study its disease process and 

complications, as it is not only causing respiratory problems, but also affecting pregnant mothers and 

their babies. Many recent studies have shown that COVID-19 infection increases the risk of developing 

preeclampsia via its effect on the placenta. This case highlights COVID-19 infection as one of the 

emerging risk factors for the development of preeclampsia and eclampsia. A 26 years old patient, 

primigravida at 28 weeks of pregnancy with no known underlying condition, was presented with one-

day history of visual disturbance, and two-week history of epigastric pain and vomiting. She had an 

uncomplicated COVID-19 infection category 2 at 20 weeks of pregnancy. During the assessment, she 

was alert but lethargic looking. Vital signs showed a blood pressure of 176/98 mmHg, a pulse rate of 

98 per minute, SpO2 of 97% and a capillary sugar level of 5.8 mmol/L. She then developed an eclamptic 

episode which prompted immediate delivery of the baby via emergency caesarean section. Post-

delivery, magnesium sulphate infusion was started, and her blood pressure was controlled with 

labetalol. Subsequently, she was discharged well after one week of admission. The baby with a weight 

of 800g was admitted to the neonatal ICU for further care. There have been studies that showed COVID-

19 infection affecting the placenta via its effect on angiotensin-converting enzyme 2 (ACE2). This 

enzyme is responsible for the haemostasis of maternal circulation and its downregulation will lead to a 

cascade of events that is similar to the pathogenesis of preeclampsia. Further research and evidence are 

needed to study this enzyme with the hopes to prevent the development of preeclampsia and eclampsia. 

 

Keywords: preeclampsia, eclampsia, COVID-19, angiotensin-converting enzyme 2 

 

___________________________________________________________________________ 

1 Hospital Kuala Lumpur, Malaysia. 

 

Correspondence to:  

Mohamad Ehsan Bin Mohamad Rosdi, Medical Officer, Hospital Kuala Lumpur (Malaysia). 

Email: sca0610@gmail.com    

_______________________________________________________________________________ 

 

 
 

 

  

DOI: http://dx.doi.org/10.31344/ijhhs.v6i0.421

mailto:sca0610@gmail.com